In contrast, expression of AURKB and TOP2A (cell cycle genes) in cancer cells was significantly downregulated after pembrolizumab treatment (Fig. 6e), indicating a reduction in cancer-cell proliferation. The gene discussed is AURKB; the disease is cancer.